Aurinia Pharmaceuticals Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Edmonton, Alberta, Canada
AUPH chart
What traders are saying about $AUPH
Latest postsAurinia Pharmaceuticals Inc. news
- Earnings Preview: Aurinia Pharmaceuticals (AUPH) Q3 Earnings Expected to Decline
Yahoo Finance ·
- Aurinia Pharmaceuticals Inc. Estimates – LSE:0UJF
TradingView ·
- Aurinia Pharmaceuticals (AUPH) Stock Looks Below Fair Value After A 136% Run
Simply Wall Street ·
- AUPH Q3'26 Earnings: revenue estimate is 83.61M USD
TradingView ·
- TD Cowen raises Aurinia Pharmaceuticals price target on cost outlook By Investing.com
Investing.com South Africa ·
- TD Cowen maintains Buy rating on Aurinia Pharmaceuticals, $18 price target
TradingView ·
- TD Cowen raises Aurinia Pharmaceuticals price target on cost outlook
Investing.com ·
- Aurinia’s (AUPH) Profits Surge While Its One Drug Just Got Company
Yahoo Finance ·
- Immatics and 4 More Stocks See Action From Activist Investors
Yahoo Finance ·
- Could Aurinia Pharmaceuticals (AUPH) Stock Win Big After its LUPKYNIS Patent Settlement With Teva Pharmaceuticals (TEVA)?
Yahoo Finance ·
- How Investors Are Reacting To Aurinia Pharmaceuticals (AUPH) Extended Voclosporin Exclusivity And Share Buyback
Yahoo Finance ·
- Aurinia Pharmaceuticals (AUPH) Stock Still Looks Cheap After A 74% Gain
Yahoo Finance ·
Aurinia Pharmaceuticals Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $283.1M | $235.1M | $175.5M | $134.0M |
| Net income | $287.2M | $5.8M | -$78.0M | -$108.2M |
| Diluted EPS | $2.07 | $0.04 | $-0.54 | $-0.76 |
| Total assets (year end) | $751.6M | $550.6M | $548.1M | $470.9M |
| Cash and equivalents (year end) | $80.2M | $83.4M | $48.8M | $94.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Aurinia Pharmaceuticals Inc.
- Ticker
- AUPH (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Edmonton, Alberta, Canada
- Fiscal year end
- December 31
- SEC CIK
- 1600620
Frequently asked questions
What exchange is Aurinia Pharmaceuticals Inc. listed on?
Aurinia Pharmaceuticals Inc. trades on the Nasdaq under the ticker symbol AUPH.
What industry is Aurinia Pharmaceuticals Inc. in?
Aurinia Pharmaceuticals Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Aurinia Pharmaceuticals Inc. headquartered?
Aurinia Pharmaceuticals Inc.'s business address on file with the SEC is in Edmonton, Alberta, Canada.
When does Aurinia Pharmaceuticals Inc.'s fiscal year end?
Aurinia Pharmaceuticals Inc.'s fiscal year ends on December 31.
How much revenue did Aurinia Pharmaceuticals Inc. report?
Aurinia Pharmaceuticals Inc. reported $283.1M in revenue for calendar year 2025, according to its SEC filings.